Protective effect of neoglycoprotein-Conjugated muramyl dipeptide against leishmania donovani infection: The role of cytokines

Kakali Sarkar, Pijush K. Das

Research output: Contribution to journalArticle

Abstract

Active targeting of muramyl dipeptide (MDP) to macrophages was studied by conjugation with the neoglycoprotein, mannosyl human serum albumin (mannose-HSA) using visceral leishmaniasis as the model macrophage disease. Conjugation did not decrease the affinity of the neoglycoprotein for macrophage mannose receptor. Mannose-HSA-MDP was 50 times more efficient than free MDP in inhibiting the growth of Leishmania donovani inside peritoneal macrophages. Moreover, in a 60-day murine model of visceral leishmaniasis, 95% of the spleen parasite burden was reduced by mannose-HSA-MDP at a dose of 0.5 mg/kg/day given for 4 days. Free MDP at a similar dose had very little effect. In vitro exposure of MDP caused enhanced generation of O2- by macrophages, whereas generation of nitric oxide (NO) was not induced. The elevated antileishmanial activity of MDP-treated macrophages in culture was abrogated by O2- scavengers. In contrast, considerably enhanced amounts of NO and O2- were generated from macrophages of mannose-HSA-MDP-treated animals, and their splenocytes secreted soluble factors providing all the signals required for the induction of NO biosynthesis. The increase in NO production was paralleled by a concomitant increase in antileishmanial activity, which was reversed by NO synthesis inhibitors. Splenocyte supernatants treated with anti-IFN-γ or anti-TNF-γ Abs suppressed inducible NO generation by macrophages. Moreover, i.v. administration of anti-IFN-γ and anti-TNF-α along with mannose-HSA-MDP greatly reduced protection against L. donovani infection. Neoglycoprotein-conjugated MDP, therefore, activated mouse macrophages in vivo to kill L. donovani, and this may depend on the physiologic generation of NO induced by IFN-γ and TNF-α.

Original languageEnglish (US)
Pages (from-to)5357-5365
Number of pages9
JournalJournal of Immunology
Volume158
Issue number11
StatePublished - 1997
Externally publishedYes

Fingerprint

Acetylmuramyl-Alanyl-Isoglutamine
Leishmania donovani
Glycoproteins
Cytokines
Macrophages
Nitric Oxide
Mannose
Infection
Visceral Leishmaniasis
Peritoneal Macrophages
Serum Albumin
Parasites
Spleen

ASJC Scopus subject areas

  • Immunology

Cite this

Protective effect of neoglycoprotein-Conjugated muramyl dipeptide against leishmania donovani infection : The role of cytokines. / Sarkar, Kakali; Das, Pijush K.

In: Journal of Immunology, Vol. 158, No. 11, 1997, p. 5357-5365.

Research output: Contribution to journalArticle

@article{9d48f48556494fc2a9e46ae4c4051c6d,
title = "Protective effect of neoglycoprotein-Conjugated muramyl dipeptide against leishmania donovani infection: The role of cytokines",
abstract = "Active targeting of muramyl dipeptide (MDP) to macrophages was studied by conjugation with the neoglycoprotein, mannosyl human serum albumin (mannose-HSA) using visceral leishmaniasis as the model macrophage disease. Conjugation did not decrease the affinity of the neoglycoprotein for macrophage mannose receptor. Mannose-HSA-MDP was 50 times more efficient than free MDP in inhibiting the growth of Leishmania donovani inside peritoneal macrophages. Moreover, in a 60-day murine model of visceral leishmaniasis, 95{\%} of the spleen parasite burden was reduced by mannose-HSA-MDP at a dose of 0.5 mg/kg/day given for 4 days. Free MDP at a similar dose had very little effect. In vitro exposure of MDP caused enhanced generation of O2- by macrophages, whereas generation of nitric oxide (NO) was not induced. The elevated antileishmanial activity of MDP-treated macrophages in culture was abrogated by O2- scavengers. In contrast, considerably enhanced amounts of NO and O2- were generated from macrophages of mannose-HSA-MDP-treated animals, and their splenocytes secreted soluble factors providing all the signals required for the induction of NO biosynthesis. The increase in NO production was paralleled by a concomitant increase in antileishmanial activity, which was reversed by NO synthesis inhibitors. Splenocyte supernatants treated with anti-IFN-γ or anti-TNF-γ Abs suppressed inducible NO generation by macrophages. Moreover, i.v. administration of anti-IFN-γ and anti-TNF-α along with mannose-HSA-MDP greatly reduced protection against L. donovani infection. Neoglycoprotein-conjugated MDP, therefore, activated mouse macrophages in vivo to kill L. donovani, and this may depend on the physiologic generation of NO induced by IFN-γ and TNF-α.",
author = "Kakali Sarkar and Das, {Pijush K.}",
year = "1997",
language = "English (US)",
volume = "158",
pages = "5357--5365",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "11",

}

TY - JOUR

T1 - Protective effect of neoglycoprotein-Conjugated muramyl dipeptide against leishmania donovani infection

T2 - The role of cytokines

AU - Sarkar, Kakali

AU - Das, Pijush K.

PY - 1997

Y1 - 1997

N2 - Active targeting of muramyl dipeptide (MDP) to macrophages was studied by conjugation with the neoglycoprotein, mannosyl human serum albumin (mannose-HSA) using visceral leishmaniasis as the model macrophage disease. Conjugation did not decrease the affinity of the neoglycoprotein for macrophage mannose receptor. Mannose-HSA-MDP was 50 times more efficient than free MDP in inhibiting the growth of Leishmania donovani inside peritoneal macrophages. Moreover, in a 60-day murine model of visceral leishmaniasis, 95% of the spleen parasite burden was reduced by mannose-HSA-MDP at a dose of 0.5 mg/kg/day given for 4 days. Free MDP at a similar dose had very little effect. In vitro exposure of MDP caused enhanced generation of O2- by macrophages, whereas generation of nitric oxide (NO) was not induced. The elevated antileishmanial activity of MDP-treated macrophages in culture was abrogated by O2- scavengers. In contrast, considerably enhanced amounts of NO and O2- were generated from macrophages of mannose-HSA-MDP-treated animals, and their splenocytes secreted soluble factors providing all the signals required for the induction of NO biosynthesis. The increase in NO production was paralleled by a concomitant increase in antileishmanial activity, which was reversed by NO synthesis inhibitors. Splenocyte supernatants treated with anti-IFN-γ or anti-TNF-γ Abs suppressed inducible NO generation by macrophages. Moreover, i.v. administration of anti-IFN-γ and anti-TNF-α along with mannose-HSA-MDP greatly reduced protection against L. donovani infection. Neoglycoprotein-conjugated MDP, therefore, activated mouse macrophages in vivo to kill L. donovani, and this may depend on the physiologic generation of NO induced by IFN-γ and TNF-α.

AB - Active targeting of muramyl dipeptide (MDP) to macrophages was studied by conjugation with the neoglycoprotein, mannosyl human serum albumin (mannose-HSA) using visceral leishmaniasis as the model macrophage disease. Conjugation did not decrease the affinity of the neoglycoprotein for macrophage mannose receptor. Mannose-HSA-MDP was 50 times more efficient than free MDP in inhibiting the growth of Leishmania donovani inside peritoneal macrophages. Moreover, in a 60-day murine model of visceral leishmaniasis, 95% of the spleen parasite burden was reduced by mannose-HSA-MDP at a dose of 0.5 mg/kg/day given for 4 days. Free MDP at a similar dose had very little effect. In vitro exposure of MDP caused enhanced generation of O2- by macrophages, whereas generation of nitric oxide (NO) was not induced. The elevated antileishmanial activity of MDP-treated macrophages in culture was abrogated by O2- scavengers. In contrast, considerably enhanced amounts of NO and O2- were generated from macrophages of mannose-HSA-MDP-treated animals, and their splenocytes secreted soluble factors providing all the signals required for the induction of NO biosynthesis. The increase in NO production was paralleled by a concomitant increase in antileishmanial activity, which was reversed by NO synthesis inhibitors. Splenocyte supernatants treated with anti-IFN-γ or anti-TNF-γ Abs suppressed inducible NO generation by macrophages. Moreover, i.v. administration of anti-IFN-γ and anti-TNF-α along with mannose-HSA-MDP greatly reduced protection against L. donovani infection. Neoglycoprotein-conjugated MDP, therefore, activated mouse macrophages in vivo to kill L. donovani, and this may depend on the physiologic generation of NO induced by IFN-γ and TNF-α.

UR - http://www.scopus.com/inward/record.url?scp=0031154584&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031154584&partnerID=8YFLogxK

M3 - Article

C2 - 9164956

AN - SCOPUS:0031154584

VL - 158

SP - 5357

EP - 5365

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 11

ER -